Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewImmunologyInflammationNephrology Open Access | 10.1172/jci.insight.199694

TNF-α Blockade Mitigates Immune Checkpoint–Related Nephritis in a Humanized Mouse Model

Victor D. Cuenca Narvaez,1 Coraima Nava Chavez,1 Omar Al Refai,1 Johanna E. J. Jacobs,2 Luis E. Gutierrez,1 Song Zhang,2 Xiaoyan Li,1 Jacob B. Hirdler,3 Michael F. Romero,1 Joerg Herrmann,2 Xiaogang Li,1 Haidong Dong,3 Alfonso Eirin,1 and Sandra M. Herrmann1

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Cuenca Narvaez, V. in: PubMed | Google Scholar

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Nava Chavez, C. in: PubMed | Google Scholar

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Al Refai, O. in: PubMed | Google Scholar

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Jacobs, J. in: PubMed | Google Scholar

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Gutierrez, L. in: PubMed | Google Scholar

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Zhang, S. in: PubMed | Google Scholar

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Li, X. in: PubMed | Google Scholar

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Hirdler, J. in: PubMed | Google Scholar

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Romero, M. in: PubMed | Google Scholar |

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Herrmann, J. in: PubMed | Google Scholar

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Li, X. in: PubMed | Google Scholar

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Dong, H. in: PubMed | Google Scholar |

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Eirin, A. in: PubMed | Google Scholar |

1Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine and Science, Rochester, United States of America

2Department of Cardiovascular Medicine, Mayo Clinic College of Medicine and Science, Rochester, United States of America

3Department of Immunology, Mayo Clinic College of Medicine and Science, Rochester, United States of America

Find articles by Herrmann, S. in: PubMed | Google Scholar

Published March 5, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.199694.
Copyright © 2026, Cuenca Narvaez et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published March 5, 2026 - Version history
View PDF
Abstract

Immune checkpoint inhibitors (ICIs) can cause immune-related adverse events (irAEs), with acute interstitial nephritis (ICI-AIN) being the most common irAE. While the exact mechanism remains unclear, upregulation of interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) pathways has been implicated. This study used a humanized chimeric PD-1/PD-L1 mouse model to assess renal effects of ICIs, alone or combined with pro-inflammatory cytokines, and to test if selective TNF-α blockade could prevent ICI-AIN. Mice were randomly divided into four experimental groups: Control, ICI-Only, ICI-Cytokines (ICI-Cyt), and ICI-Block (ICI-TNF-α blockade). Renal function and cytokine profiles were assessed, while kidney tissue was analyzed using microscopy and single-cell RNA sequencing. Histology revealed increased renal infiltration of CD4⁺/CD8⁺ T cells in ICI-treated groups and decreased TNF-α expression following TNF-α blockade. Additionally, kidney tissue ELISA demonstrated reduced IFN-γ levels following TNF-α blockade. Plasma IL-6, MCP-1, and TNF-α were lower in ICI-Block mice. Single-cell RNA sequencing revealed shifts in immune cell populations and genes of interest including: Bcl2a1, Icos, Il18r1, Ccr2, and Jaml. This humanized model replicates ICI-AIN key features, revealing a synergistic role of ICIs and pro-inflammatory cytokines. TNF-α blockade demonstrated protective effects, supporting its potential role in mitigating the risk of ICI-AIN.

Supplemental material

View

Version history
  • Version 1 (March 5, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts